Large-scale testing (Phase 3)Enrolling By InvitationNCT06873035
What this trial is testing
An Interventional Study of Infigratinib in Children With Hypochondroplasia
Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 24